New patent expiration for Takeda Pharms drug DEXILANT
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from four suppliers.
Sun.Apr 14, 2024
59 
Risk-Based Auditing and its Application to GLP Computerized System Validation Procedures
Alta Sciences
APRIL 14, 2024
Risk-Based Auditing and its Application to GLP Computerized System Validation Procedures iianiro Sun, 04/14/2024 - 20:49 URL [link] Date of publication April 11, 2024 Category Poster Weight 1
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.
Collaborating for Success Tips for Improving Partnerships Between QA and Clinical Operations at Your Sitei
Alta Sciences
APRIL 14, 2024
Collaborating for Success Tips for Improving Partnerships Between QA and Clinical Operations at Your Sitei iianiro Sun, 04/14/2024 - 21:17 Image SQA_2024_Collaborations_for_Success_0.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
New patent expiration for Astrazeneca Ab drug FARXIGA
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from five suppliers.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
New patent for Astrazeneca drug TAGRISSO
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for TAGRISSO Tagrisso is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier.
New patent for Azurity drug EPRONTIA
Drug Patent Watch
APRIL 14, 2024
Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier.
Drug Patent Expirations for the Week of April 14, 2024
Drug Patent Watch
APRIL 14, 2024
DEXILANT (dexlansoprazole) Takeda pharms usa Patent: 8,722,084 Expiration: Apr 15, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
Which pharmaceutical companies have the most drug patents in New Zealand?
Drug Patent Watch
APRIL 14, 2024
This chart shows the pharmaceutical companies with the most patents in New Zealand.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Let's personalize your content